AMB-CHMINACA

AMB-CHMINACA

Legal status
Legal status	CA: Schedule II
Identifiers
IUPAC name methyl (2S)-2-{[1-(cyclohexylmethyl)indazole-3-carbonyl]amino}-3-methylbutanoate
CAS Number	1863066-03-8(racemate)
PubChem CID	119026010
ChemSpider	32055578
UNII	OU56JJP891
Chemical and physical data
Formula	C21H29N3O3
Molar mass	371.5 g/mol
3D model (JSmol)	Interactive image
SMILES COC([C@H](C(C)C)NC(C1=NN(C2=C1C=CC=C2)CC3CCCCC3)=O)=O
InChI InChI=1S/C21H29N3O3/c1-14(2)18(21(26)27-3)22-20(25)19-16-11-7-8-12-17(16)24(23-19)13-15-9-5-4-6-10-15/h7-8,11-12,14-15,18H,4-6,9-10,13H2,1-3H3,(H,22,25)/t18-/m0/s1 Key:CRGGXDSTBHQLKJ-SFHVURJKSA-N

AMB-CHMINACA (also known as MA-CHMINACA) is an indazole-based synthetic cannabinoid^[1] that is a potent agonist of the CB₁ receptor and has been sold online as a designer drug.^[2][3][4]

Legal status

AMB-CHMINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.^[5]

See also

References

1. ↑ Akamatsu, Shigeki; Yoshida, Masashi (January 2016). "Fragmentation of synthetic cannabinoids with an isopropyl group or a tert-butyl group ionized by electron impact and electrospray". Journal of Mass Spectrometry. 51 (1): 28–32. doi:10.1002/jms.3722. 
2. ↑ "MA-CHMINACA". Cayman Chemical. Retrieved 21 July 2015. 
3. ↑ "MA-CHMINACA". Southern Association of Forensic Scientists. Retrieved 21 July 2015. 
4. ↑ Samuel D Banister; et al. (July 2016). "The pharmacology of valinate and tert-leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues". ACS Chemical Neuroscience. 7: 1241–54. PMID 27421060. doi:10.1021/acschemneuro.6b00137. CS1 maint: Explicit use of et al. (link)
5. ↑ "CNB NEWS RELEASE". Central Narcotics Bureau (CNB). 30 April 2015. Retrieved 21 July 2015.